January 21, 2023

July 2022: Meducom supports development of information cards for patients

When patients are diagnosed with cancer, they may be overwhelmed with questions. What is going…
Read More
January 21, 2023

March 2022: Meducom supports important publication on reduced cardiotoxicity after switch to another chemotherapy

Fluoropyrimidine chemotherapy is widely used in many solid tumours, but is associated with cardiotoxicity. In…
Read More
January 21, 2023

January 2022: EMA approves dossier for new indication for drug in metastatic colorectal cancer

During most of 2021, Meducom worked hard to support a client and clinical experts in…
Read More
January 9, 2018

December 2017: Meducom supports advisory board

Shortly before the holidays, Meducom developed and organised a nephrology advisory board in Belgium for…
Read More